New Global Survey Reveals Shift in Clinical Trial Priorities; Payment Efficiencies Emerge as Leading...
Greenphire, the global leader in financial lifecycle management for clinical trials, announced results from its...
Advanced Cancers Are Tackled By Genetically Altered Herpes
A quarter of patients with a variety of advanced tumours have shown signals of benefit...
EC Authorizes Opdualag From BMS As A Melanoma Treatment
The fixed-dose combination Opdualag (nivolumab and relatlimab) from Bristol Myers Squibb (BMS) has received clearance...
GAVI Funds To Enable Quick Finances For The Next Pandemic
According to Chief Executive Seth Berkley of the global vaccination alliance GAVI, the organisation has...
Bluebird Hits $3m Mark With Gene Therapy After FDA Approval
Within one firm, the title of most costly treatment in the world has changed hands...
First Next-Gen Parkinsons Med To Be Made By Neuron23, QIAGEN
QIAGEN and Neuron23TM Inc., an early-stage biotechnology company focused on creating precision medications for genetically...
Australia Permits New Treatment For Rare Bile Duct Cancer
Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma,...
Beyfortus From Sanofi And Astrazeneca Is Supported By RSV
Beyfortus has received approval from the Committee for Medicinal Products for Human Use (CHMP) of...
canSERV, EU Cluster Effort, Offers Cancer Study In Europe
Brussels marks the beginning of the European canSERV initiative, which aims to defragment the European...
WHO Strongly Advises Against The Use of 2 COVID Therapies
The World Health Organization (WHO) has discontinued the use of two COVID-19 antibody treatments on...
